Presented for attendees of The Liver Meeting Digital Experience™. This event/function is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC and supported by medical education grants from Eisai Inc., Exelixis, Inc., Genentech, a member of the Roche Group, and Merck & Co., Inc. This is not an official function/event of the American Association for the Study of Liver Diseases.
Saturday, November 14, 2020
7:00 PM – 8:00 PM ET
WHO SHOULD ATTEND?
This activity is intended for hepatology, hematology/oncology, and other clinicians including physicians, NPs, and PAs who diagnose and manage patients with hepatocellular carcinoma (HCC).
OBJECTIVES FOR ATTENDEES
After engaging in this activity, clinicians will be able to:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points and 0 patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This activity is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC.
This educational activity is supported by medical education grants from Eisai Inc., Exelixis, Inc., Genentech, a member of the Roche Group, and Merck & Co., Inc.
CRITERIA FOR SUCCESS
Statements of credit will be awarded based on the participant’s attendance, participation in the pre-/post-test, and submission of the activity evaluation form. A statement of credit will be available upon completion of an evaluation/claimed credit form. If you have questions about this CME activity, please contact AKH Inc. at email@example.com.
There is no fee for this educational activity.
Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.